Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway

被引:65
作者
Bermudez, O. [1 ]
Marchetti, S. [1 ]
Pages, G. [1 ]
Gimond, C. [1 ]
机构
[1] Univ Nice Sophia Antipolis, CNRS, Ctr Antoine Lacassagne, Inst Signaling Dev Biol & Canc Res,UMR 6543, F-06189 Nice, France
关键词
ERK phosphatase DUSP6/MKP-3; mTOR; phosphorylation; degradation;
D O I
10.1038/sj.onc.1211040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MAP kinases phosphatases (MKPs) belong to the dual-specificity phosphatase family (DUSP) and dephosphorylate phosphothreonine and phosphotyrosine within MAP kinases. We had previously shown that DUSP6/MKP-3 was phosphorylated and degraded upon growth factor stimulation, in a MEK-dependent manner. Here we show that another pathway involved in growth factor signaling, the PI3K/mTOR signaling pathway, accounts for a part of the phosphorylation and degradation of DUSP6 induced by serum growth factors, as evidenced by experiments using pharmacological inhibitors of PI3 kinase and mammalian target of rapamycin (mTOR). Moreover, specific agonists of the mTOR pathway, such as amino acids or insulin/IGF-1, which do not activate extracellular signal regulated kinases (ERKs) in our cellular model, were also able to induce the phosphorylation and degradation of DUSP6. However, a basal activity of MEK was required for the mTOR pathway-mediated phosphorylation to occur. Mutagenesis studies identified serine 159 within DUSP6 as the target of the mTOR pathway. The ERK phosphatase DUSP6 may thus constitute a novel branch-point of the crosstalk between two major signaling pathways induced by growth factors, the MEK/ERK pathway and the PI3K/mTOR pathway.
引用
收藏
页码:3685 / 3691
页数:7
相关论文
共 22 条
[1]   When translation meets transformation: the mTOR story [J].
Averous, J. ;
Proud, C. G. .
ONCOGENE, 2006, 25 (48) :6423-6435
[2]   Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase [J].
Avruch, J. ;
Hara, K. ;
Lin, Y. ;
Liu, M. ;
Long, X. ;
Ortiz-Vega, S. ;
Yonezawa, K. .
ONCOGENE, 2006, 25 (48) :6361-6372
[3]   Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase [J].
Camps, M ;
Nichols, A ;
Gillieron, C ;
Antonsson, B ;
Muda, M ;
Chabert, C ;
Boschert, U ;
Arkinstall, S .
SCIENCE, 1998, 280 (5367) :1262-1265
[4]   ERK implication in cell cycle regulation [J].
Chambard, Jean-Claude ;
Lefloch, Renaud ;
Pouyssegur, Jacques ;
Lenormand, Philippe .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (08) :1299-1310
[5]   Mkp3 is a negative feedback modulator of Fgf8 signaling in the mammalian isthmic organizer [J].
Echevarria, D ;
Martinez, S ;
Marques, S ;
Lucas-Teixeira, V ;
Belo, JA .
DEVELOPMENTAL BIOLOGY, 2005, 277 (01) :114-128
[6]   The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins [J].
Harrington, LS ;
Findlay, GM ;
Gray, A ;
Tolkacheva, T ;
Wigfield, S ;
Rebholz, H ;
Barnett, J ;
Leslie, NR ;
Cheng, S ;
Shepherd, PR ;
Gout, I ;
Downes, CP ;
Lamb, RE .
JOURNAL OF CELL BIOLOGY, 2004, 166 (02) :213-223
[7]   Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses [J].
Jeffrey, Kate L. ;
Camps, Montserrat ;
Rommel, Christian ;
Mackay, Charles R. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (05) :391-403
[8]   MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb [J].
Kawakami, Y ;
Rodríguez-León, J ;
Koth, CM ;
Büscher, D ;
Itoh, T ;
Raya, A ;
Ng, JK ;
Esteban, CR ;
Takahashi, S ;
Henrique, D ;
Schwarz, MF ;
Asahara, H ;
Belmonte, JCI .
NATURE CELL BIOLOGY, 2003, 5 (06) :513-519
[9]   MKP-3 has essential roles as a negative regulator of the Ras/mitogen-activated protein kinase pathway during Drosophila development [J].
Kim, M ;
Cha, GH ;
Kim, S ;
Lee, JH ;
Park, J ;
Koh, H ;
Choi, KY ;
Chung, JK .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (02) :573-583
[10]   Hypoxia-inducible factor 1α is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif [J].
Land, Stephen C. ;
Tee, Andrew R. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (28) :20534-20543